Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZIMBERELIMAB vs ZIPRASIDONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ZIMBERELIMAB vs ZIPRASIDONE: Safety Overview

Metric ZIMBERELIMAB ZIPRASIDONE
Total FAERS Reports 193 3,551
Deaths Reported 62 515
Death Rate 32.1% 14.5%
Hospitalizations 181 1,164
Average Patient Age 63.6 yrs 37.6 yrs
% Female Patients 48.3% 55.8%
FDA Approval Date N/A Aug 22, 2017
Manufacturer N/A Apotex Corp.
Route N/A ORAL
Marketing Status N/A Prescription